It has been reported that alteration of SWI/SNF function promotes cancer progression and that somatic inactivation of specific components of SWI/SNF are present in various human cancers [120], suggesting tumor-suppressor activity of this complex. The gene discussed is SMARCA1; the disease is cancer.